Lunch Seminar

Tsung-Mei Cheng, Health Policy Analyst, Woodrow Wilson School of Public and International Affairs

Tsung-Mei Cheng is a Health Policy Research Analyst at the Woodrow Wilson School of Public and International Affairs. She is cofounder of the Princeton Conference, an annual national conference on health policy that brings together the U.S. Congress, government, and the research community on issues affecting health care and health policy in the United States. 

Cheng’s current research focuses on cross-national comparisons of health systems in East Asia, health reforms in China and Taiwan, health technology assessment and comparative effectiveness research, health care quality, financing, payment reform, including evidence based guidelines and pay for performance (P4P) in East Asian health systems.

Cheng is an adviser to the China National Health Development Research Center (CNHDRC), the official Chinese government think tank for health policy under China’s Ministry of Health. She is also an advisor to the National Institute for Health and Clinical Excellence-International of the United Kingdom, which advices governments and agencies overseas on capacity building for evidence base to inform national health policy as well as knowledge transfer among decision-makers across national borders.

Cheng is a member of the Emerging Market Symposium (EMS) Steering Committee, an Oxford University based initiative that addresses pressing sectoral issues facing emerging market countries, and serves on the International Advisory Board of the Elsevier On-line Encyclopedia of Health Economics, the on-line publication by the publisher of medical and scientific literature (The Lancet, Cell, Gray’s Anatomy, ScienceDirect, etc.) designed to meet the needs of the rapidly changing and growing field of health economics which calls for timely “authoritative articles on key concepts, issues, theory and methods” in health economics. Cheng also serves on the Technical Advisory Committee of the Global Task Force on Expanded Access to Cancer Care and Control (GTF.CCC), an initiative convened by the Harvard Global Equity Initiative, the Harvard Medical School, the Harvard School of Public Health and the Dana Farber Cancer Institute to combat cancer in developing countries. She is a member of the editorial advisory board of the health policy journal Health Affairs.

In 2003, Cheng served as an adviser to the Strategic Review Board of the Science and Technology Advisory Group (STAG), which advises the Office of the Premier of Taiwan on policies relating to the development of science and technology including health care in Taiwan. Cheng was a member of the International Advisory Group of AcademyHealth, the US-based professional association of health services researchers.

Lunch will be served.

RSVP required. Non-WWS students: to RSVP, email [email protected] by February 6th. WWS students will receive a separate invitation on the week prior to the event.

This event is co-sponsored by the Woodrow Wilson School's Center for Health and Wellbeing.